Co-Hosted By:
Join leading scientists, industry experts, and regulatory stakeholders for a two-day in-person workshop on End-to-End Analytical Solutions for mRNA Therapeutics: Supporting Manufacturing and CMC Needs, focused on advancing analytical strategies for mRNA therapeutics.
Explore critical aspects of Chemistry, Manufacturing, and Controls (CMC) for mRNA-based products, with sessions dedicated to raw material qualification, innovative analytical methods, platform technologies, and emerging applications such as cancer vaccines and gene therapies.
This workshop is ideal for professionals involved in mRNA development, manufacturing, and regulatory affairs who are seeking to deepen their understanding of analytical requirements and platform strategies in this rapidly evolving field.
The agenda will include presentations and discussions on:
ScopeSys Inc.
CLiC analytical platform for the multi-parametric characterization of mRNA–LNP therapeutics
Sanofi
Platform-Based Analytical Strategies to Accelerate mRNA-LNP Product Development: Applicability and Case Studies
National Institute of Standards and Technology
Comparability of analytical techniques that assess mRNA drug-substance CQAs: NIST RGTM 10202 FLuc mRNA
Waters Corporation
Advances in mRNA analysis with liquid chromatography methods
Refeyn
Mass Photometry as a Multiple-Attribute Tool for mRNA Therapeutic Development
Molgenium
A Novel RIG I Based Assay for Quantitative Detection of dsRNA Contaminants in RNA therapeutics
Johns Hopkins University
Messenger RNA and Guide RNA Distributions in Lipid Nanoparticles Impact Gene Editing Efficiency In Vivo: A framework for RNA LNP rational design guided by single-particle attributes
Pfizer
DNA starting material control strategy
Eclipsebio
Integrating Sequencing Analytics into mRNA Manufacturing and Quality Control
Molgenium
A Novel RIF I Based Assay for Quantitative Detection of dsRNA Contaminants in RNA therapeutics
Pfizer
DNA starting material control strategy
Johns Hopkins University
Messenger RNA and Guide RNA Distributions in Lipid Nanoparticles Impact Gene Editing Efficiency In Vivo: A framework for RNA LNP rational design guided by single-particle attributes
The full line up of speakers will be available soon!
Hear scientific presentations on cutting-edge analytical methods and CQA assessment
Gain insights into the correlation between physical and functional characteristics of mRNA products
Explore applications of mRNA across diverse therapeutic modalities
Contribute as a speaker through abstract submission
Alliance for mRNA Medicines uses cookies and other tracking technologies to enhance your experience, provide personalized content and ads, and analyze our traffic. Alliance for mRNA Medicines uses cookies and other tracking technologies to enhance your experience, provide personalized content and ads, and analyze our traffic. These cookies may be set by us or by third-party partners. Non-essential cookies will only be used if you give your consent. You can manage your preferences at any time through the Cookie Settings link. If you are a California resident, you have the right to opt out of the sale or sharing of your personal information. Selecting "Decline All" will opt you out of non-essential cookies and any such data sharing. To learn more, please see our Privacy Policy. Read more